{"entity":{"type":"insider","cik":"0001719115","url":"/insider/0001719115","json_url":"/insider/0001719115.json","name":"Griffin Deborah A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":11,"first":"2018-03-06","last":"2020-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Griffin Deborah A","source":"filing","n_filings":11,"first_seen":"2018-03-06","last_seen":"2020-03-19"}],"transactions":[{"id":2878580,"accession":"0001209191-20-020167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020167","line_url":"/filing/0001209191-20-020167#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":944.0,"shares_display":"944","price_per_share":7.1635,"price_display":"7.16","price_state":"stated","total_value":6762.344,"total_display":"6,762.34","total_whole":"6,762","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":3008110,"accession":"0001209191-20-016462","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016462","line_url":"/filing/0001209191-20-016462#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4807.0,"shares_display":"4,807","price_per_share":11.2294,"price_display":"11.23","price_state":"stated","total_value":53979.7258,"total_display":"53,979.73","total_whole":"53,980","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-04","filed_date":"2020-03-05","scope":"insider"},{"id":3255331,"accession":"0001209191-20-015874","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-015874","line_url":"/filing/0001209191-20-015874#line-4","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1166.0,"shares_display":"1,166","price_per_share":11.3658,"price_display":"11.37","price_state":"stated","total_value":13252.5228,"total_display":"13,252.52","total_whole":"13,253","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-04","scope":"insider"},{"id":3255308,"accession":"0001209191-20-015874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-015874","line_url":"/filing/0001209191-20-015874#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2941.0,"shares_display":"2,941","price_per_share":11.5989,"price_display":"11.60","price_state":"stated","total_value":34112.3649,"total_display":"34,112.36","total_whole":"34,112","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":8600942,"accession":"0001209191-19-050263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-050263","line_url":"/filing/0001209191-19-050263#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2376.0,"shares_display":"2,376","price_per_share":7.8313,"price_display":"7.83","price_state":"stated","total_value":18607.1688,"total_display":"18,607.17","total_whole":"18,607","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":8486479,"accession":"0001209191-19-020158","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020158","line_url":"/filing/0001209191-19-020158#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":943.0,"shares_display":"943","price_per_share":16.6251,"price_display":"16.63","price_state":"stated","total_value":15677.4693,"total_display":"15,677.47","total_whole":"15,677","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":8645290,"accession":"0001209191-19-019328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019328","line_url":"/filing/0001209191-19-019328#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":953.0,"shares_display":"953","price_per_share":15.6749,"price_display":"15.67","price_state":"stated","total_value":14938.1797,"total_display":"14,938.18","total_whole":"14,938","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":7945965,"accession":"0001209191-19-016087","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-016087","line_url":"/filing/0001209191-19-016087","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4107.0,"shares_display":"4,107","price_per_share":16.8833,"price_display":"16.88","price_state":"stated","total_value":69339.7131,"total_display":"69,339.71","total_whole":"69,340","shares_owned_after":1166.0,"shares_owned_after_display":"1,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-05","scope":"insider","n_lines":2},{"id":6202116,"accession":"0001209191-18-051775","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-051775","line_url":"/filing/0001209191-18-051775#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2376.0,"shares_display":"2,376","price_per_share":23.707,"price_display":"23.71","price_state":"stated","total_value":56327.832,"total_display":"56,327.83","total_whole":"56,328","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":6604279,"accession":"0001209191-18-020860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020860","line_url":"/filing/0001209191-18-020860#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":943.0,"shares_display":"943","price_per_share":17.878,"price_display":"17.88","price_state":"stated","total_value":16858.954,"total_display":"16,858.95","total_whole":"16,859","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-20","scope":"insider"},{"id":6420648,"accession":"0001209191-18-019563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-019563","line_url":"/filing/0001209191-18-019563#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":952.0,"shares_display":"952","price_per_share":19.489,"price_display":"19.49","price_state":"stated","total_value":18553.528,"total_display":"18,553.53","total_whole":"18,554","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"},{"id":6393936,"accession":"0001209191-18-017210","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-017210","line_url":"/filing/0001209191-18-017210#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001719115","owner_name":"Griffin Deborah A","owner_display_name":"Griffin Deborah A","owner_url":"/insider/0001719115","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":773.0,"shares_display":"773","price_per_share":19.38,"price_display":"19.38","price_state":"stated","total_value":14980.74,"total_display":"14,980.74","total_whole":"14,981","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (Chief Accounting Officer)","n_filings":11,"first_seen":"2018-03-06","last_seen":"2020-03-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001719115","retrieved_at":"2026-08-26T23:54:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}